T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Jones Lang LaSalle
JLL
$17B
| $226M | 0.06% |
2,588,110
+537,500
| +26% | +$47.9M |
|
377
Sun Life Financial
SLF
$44.8B
| $223M | 0.06% |
6,987,500
+17,200
| +0.2% | +$547K |
|
378
SS&C Technologies
SSNC
$19.3B
| $223M | 0.06% |
11,726,976
-29,780
| -0.3% | -$541K |
|
|
FEIC
379
DELISTED
FEI COMPANY
FEIC
| $222M | 0.06% |
2,529,701
+1,476,951
| +140% | +$117M |
|
380
Vail Resorts
MTN
$5.18B
| $219M | 0.05% |
3,163,260
+16,400
| +0.5% | +$1.11M |
|
381
Adtran
ADTN
$658M
| $218M | 0.05% |
8,194,253
-736,520
| -8% | -$19.1M |
|
382
Global Payments
GPN
$25.1B
| $216M | 0.05% |
8,460,064
-139,900
| -2% | -$3.38M |
|
|
KATE
383
DELISTED
Kate Spade & Company
KATE
| $215M | 0.05% |
8,554,590
+675,080
| +9% | +$16.4M |
|
384
BP
BP
$110B
| $214M | 0.05% |
6,237,085
-796,381
| -11% | -$27.3M |
|
385
Macerich
MAC
$6.99B
| $214M | 0.05% |
3,797,017
+124,450
| +3% | +$7.47M |
|
386
Iron Mountain
IRM
$37.7B
| $213M | 0.05% |
8,538,353
+5,642,089
| +195% | +$143M |
|
387
Lennox International
LII
$14.5B
| $212M | 0.05% |
2,810,570
-7,620
| -0.3% | -$538K |
|
|
SAPE
388
DELISTED
SAPIENT CORP
SAPE
| $211M | 0.05% |
13,550,251
-102,750
| -0.8% | -$1.52M |
|
389
Goldman Sachs
GS
$304B
| $211M | 0.05% |
1,331,818
-540,702
| -29% | -$87M |
|
390
IPG Photonics
IPGP
$3.57B
| $210M | 0.05% |
3,723,230
-217,144
| -6% | -$12.7M |
|
391
Travelers Companies
TRV
$77.2B
| $209M | 0.05% |
2,470,257
+288,085
| +13% | +$23.8M |
|
392
RBC Bearings
RBC
$17.5B
| $209M | 0.05% |
3,167,300
+95,600
| +3% | +$5.61M |
|
|
AGN
393
DELISTED
Allergan plc
AGN
| $208M | 0.05% |
1,441,809
+783,578
| +119% | +$104M |
|
394
Mine Safety
MSA
$7.32B
| $207M | 0.05% |
4,015,230
+242,560
| +6% | +$12.4M |
|
395
BioMarin Pharmaceuticals
BMRN
$13.3B
| $205M | 0.05% |
2,844,230
-97,060
| -3% | -$6.45M |
|
396
Air Products & Chemicals
APD
$68B
| $204M | 0.05% |
2,071,417
+95,672
| +5% | +$9.09M |
|
397
Abbott
ABT
$193B
| $203M | 0.05% |
6,125,432
-974,430
| -14% | -$34.2M |
|
|
DF
398
DELISTED
Dean Foods Company
DF
| $203M | 0.05% |
10,507,000
+2,906,750
| +38% | +$58.8M |
|
|
CAM
399
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $202M | 0.05% |
3,455,240
-2,000,965
| -37% | -$119M |
|
400
CenterPoint Energy
CNP
$26.7B
| $199M | 0.05% |
8,317,890
+162,335
| +2% | +$3.87M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.